Needle-knife therapy improves the clinical symptoms of knee osteoarthritis by inhibiting the expression of inflammatory cytokines

Lin,Munan; Li,Xihai; Liang,Wenna; Liu,Jianhua; Guo,Jianhong; Zheng,Jingxiong; Liu,Xianxiang

doi:10.3892/etm.2014.1516

Needle-knife therapy improves the clinical symptoms of knee osteoarthritis by inhibiting the expression of inflammatory cytokines

Authors:
- Munan Lin
- Xihai Li
- Wenna Liang
- Jianhua Liu
- Jianhong Guo
- Jingxiong Zheng
- Xianxiang Liu
View Affiliations

Affiliations: Department of Traditional Chinese Medicine, Fuzhou General Hospital of Nanjing Military Command, Fuzhou, Fujian 350025, P.R. China, Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350108, P.R. China, Research Base of Traditional Chinese Medicine Syndrome, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China
Published online on: January 30, 2014 https://doi.org/10.3892/etm.2014.1516
Pages: 835-842

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Knee osteoarthritis (KOA) is a degenerative joint disease that occurs mainly in the elderly population. However, there are currently no effective treatments for treating this condition. In this study, the efficacy of needle‑knife therapy, a technique of traditional Chinese medicine that has been widely used to treat KOA was investigated. Patients (n=170) with KOA were randomly divided for needle‑knife therapy (treatment group) and acupuncture therapy (control group). Outcome evaluation included stiffness, pain, physiological function, overall changes, total symptom score, clinical curative effects and the concentrations of interleukin (IL)-1β, IL-6 and tumor necrosis factor-α (TNF‑α) in the synovial fluid. The trial was completed in 151 patients (233 knees) from a total of 170 patients (264 knees); the treatment group comprised 76 patients (117 knees) who completed the trial and 9 patients (14 knees) who were removed from the study, and the control group comprised 75 patients (116 knees) who completed the trial and 10 patients (17 knees) who were removed from the study. The symptom scores of KOA in stages I-IV were reduced significantly in the treatment group and those of stages I-III were decreased significantly in the control group. The effective rate of the KOA therapy in the patients of stages III and IV in the treatment group was significantly higher than that in the control group. After treatment, the decrements of IL-1β, IL-6 and TNF-α in the treatment group were greater than those in the control group. These results showed that the use of needle‑knife therapy to treat KOA effectively improved the clinical symptoms by inhibiting the expression of inflammatory cytokines.

View Figures

View References

1	Li XH, Peng J, Xu YF, et al: Tetramethylpyrazine (TMP) promotes chondrocyte proliferation via pushing the progression of cell cycle. J Med Plants Res. 5:3896–3903. 2011.
2	Li X, Lang W, Ye H, et al: Tougu Xiaotong capsule inhibits the tidemark replication and cartilage degradation of papain-induced osteoarthritis by the regulation of chondrocyte autophagy. Int J Mol Med. 31:1349–1356. 2013.
3	Sarzi-Puttini P, Cimmino MA, Scarpa R, et al: Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum. 35(1 Suppl 1): 1–10. 2005. View Article : Google Scholar
4	Felson DT, Lawrence RC, Dieppe PA, et al: Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 133:635–646. 2000. View Article : Google Scholar : PubMed/NCBI
5	No authors listed. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 43:1905–1915. 2000. View Article : Google Scholar : PubMed/NCBI
6	Jordan KM, Arden NK, Doherty M, et al; Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 62:1145–1155. 2003. View Article : Google Scholar
7	Hamburger MI, Lakhanpal S, Mooar PA and Oster D: Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum. 32:296–309. 2003. View Article : Google Scholar : PubMed/NCBI
8	Felson DT, Lawrence RC, Hochberg MC, et al: Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med. 133:726–737. 2000. View Article : Google Scholar : PubMed/NCBI
9	Blower AL, Brooks A, Fenn GC, et al: Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther. 11:283–291. 1997. View Article : Google Scholar : PubMed/NCBI
10	McGettigan P and Henry D: Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 296:1633–1644. 2006. View Article : Google Scholar : PubMed/NCBI
11	Health Quality Ontario. Arthroscopic lavage and debridement for osteoarthritis of the knee: an evidence-based analysis. Ont Health Technol Assess Ser. 5:1–37. 2005.PubMed/NCBI
12	Fu MY and Zhang ZL: Knee osteoarthritis treated with acupuncture at the points selected according to syndrome differentiation: a randomized controlled trial. Zhongguo Zhen Jiu. 31:1062–1066. 2011.(In Chinese).
13	Ahsin S, Saleem S, Bhatti AM, Iles RK and Aslam M: Clinical and endocrinological changes after electro-acupuncture treatment in patients with osteoarthritis of the knee. Pain. 147:60–66. 2009. View Article : Google Scholar : PubMed/NCBI
14	Wu MX, Li XH, Lin MN, et al: Clinical study on the treatment of knee osteoarthritis of Shen-Sui insufficiency syndrome type by electroacupuncture. Chin J Integr Med. 16:291–297. 2010. View Article : Google Scholar : PubMed/NCBI
15	Zeng GG, Zhang XF, Quan WC, et al: Effects of needle knife relaxing therapy on tension of local soft tissue and pain of osteoarthritis of knee. Zhongguo Zhen Jiu. 28:244–247. 2008.(In Chinese).
16	Lu D, Xu WX, Ding WG, Guo QF, Ma GP and Zhu WM: Case-control study on needle-knife to cut off the medial branch of the lumbar posterior ramus under C-arm guiding for the treatment of low back pain caused by lumbar facet osteoarthritis. Zhongguo Gu Shang. 26:214–217. 2013.(In Chinese).
17	Guo CQ, Ji B, Chen YN, et al: Affection of acupotomy lysis on leu-enkephalin (L-ENK) content in different parts of centrum of rats with knee osteoarthritis. Zhongguo Gu Shang. 24:656–658. 2011.(In Chinese).
18	Hawker GA, Mian S, Bednis K and Stanaitis I: Osteoarthritis year 2010 in review: non-pharmacologic therapy. Osteoarthritis Cartilage. 19:366–374. 2011.PubMed/NCBI
19	Oliveria SA, Felson DT, Reed JI, Cirillo PA and Walker AM: Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 38:1134–1141. 1995. View Article : Google Scholar : PubMed/NCBI
20	Sharif M, George E and Dieppe PA: Correlation between synovial fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in osteoarthritis of the knee. Arthritis Rheum. 38:78–81. 1995. View Article : Google Scholar : PubMed/NCBI
21	Li XH, Liang WN and Liu XX: Clinical observation on curative effect of dissolving phlegm-stasis on 50 cases of knee osteoarthritis. J Tradit Chin Med. 30:108–112. 2010. View Article : Google Scholar : PubMed/NCBI
22	Wang HM, Liu JN and Zhao Y: Progress on integrated Chinese and Western medicine in the treatment of osteoarthritis. Chin J Integr Med. 16:378–384. 2010. View Article : Google Scholar : PubMed/NCBI
23	Mao JJ and Kapur R: Acupuncture in primary care. Prim Care. 37:105–117. 2010. View Article : Google Scholar
24	Li HY, Cui L, Cui M and Tong YY: Active research fields of acupuncture research: a document co-citation clustering analysis of acupuncture literature. Altern Ther Health Med. 16:38–45. 2010.PubMed/NCBI
25	Lechner M, Steirer I, Brinkhaus B, et al: Efficacy of individualized Chinese herbal medication in osteoarthrosis of hip and knee: a double-blind, randomized-controlled clinical study. J Altern Complement Med. 17:539–547. 2011. View Article : Google Scholar : PubMed/NCBI
26	Tan C, Wang J, Feng W, Ding W and Wang M: Preliminary correlation between warm needling treatment for knee osteoarthritis of deficiency-cold syndrome and metabolic functional genes and pathways. J Acupunct Meridian Stud. 3:173–180. 2010. View Article : Google Scholar : PubMed/NCBI
27	Li XH, Wu MX, Ye HZ, et al: Experimental study on the suppression of sodium nitroprussiate-induced chondrocyte apoptosis by Tougu Xiaotong Capsule-containing serum. Chin J Integr Med. 17:436–443. 2011. View Article : Google Scholar
28	Goldring MB and Goldring SR: Osteoarthritis. J Cell Physiol. 213:626–634. 2007. View Article : Google Scholar : PubMed/NCBI
29	Yuan PW, Liu DY, Chu XD, Hao YQ, Zhu C and Qu Q: Effects of preventive administration of juanbi capsules on TNF-alpha, IL-1 and IL-6 contents of joint fluid in the rabbit with knee osteoarthritis. J Tradit Chin Med. 30:254–258. 2010. View Article : Google Scholar : PubMed/NCBI
30	Goldring MB and Berenbaum F: The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res. 427(Suppl): S37–S46. 2004. View Article : Google Scholar : PubMed/NCBI
31	Smith RL, Allison AC and Schurman DJ: Induction of articular cartilage degradation by recombinant interleukin 1 alpha and 1 beta. Connect Tissue Res. 18:307–316. 1989. View Article : Google Scholar : PubMed/NCBI
32	Fernandes JC, Martel-Pelletier J and Pelletier JP: The role of cytokines in osteoarthritis pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
33	Stöve J, Huch K, Günther KP and Scharf HP: Interleukin-1beta induces different gene expression of stromelysin, aggrecan and tumor-necrosis-factor-stimulated gene 6 in human osteoarthritic chondrocytes in vitro. Pathobiology. 68:144–149. 2000.PubMed/NCBI
34	Porée B, Kypriotou M, Chadjichristos C, et al: Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1. Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J Biol Chem. 283:4850–4865. 2008.
35	Saklatvala J: Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 322:547–549. 1986. View Article : Google Scholar : PubMed/NCBI
36	Goldring MB, Fukuo K, Birkhead JR, Dudek E and Sandell LJ: Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes. J Cell Biochem. 54:85–99. 1994. View Article : Google Scholar : PubMed/NCBI